Since 1980, Gerbsman Partners has focused on maximizing enterprise value for highly leveraged,
under-performing, under-valued and under-capitalized companies and their Intellectual Property.

Gerbsman Partners has also assisted numerous emerging growth and middle market companies
develop and execute their financial and capital formation strategies, access the capital markets
and provide for technology and life science strategic alliances and licensing of Intellectual Property.

Since 2001, Gerbsman Partners has been involved in 41 technology and life science companies and has
restructured/terminated over $ 740 million of prohibitive real estate leases, equipment leases, sub-debt and creditor issues. To date, Gerbsman Partners has been involved in over $ 2.2 billion of restructurings, M&A and financing transactions.